This IDC Health Insights report details IT spending expectations for the life science manufacturing and supply chain industry segment, which is currently projected to experience strengthening growth during 2012.
Eric Newmark, program director at IDC Health Insights, commented, "Life science companies are exploring opportunities to further optimize manufacturing and supply chain processes to help solve several industry challenges. Broader procurement diversification is needed to fight current drug shortages, outsourcing initiatives are expanding to facilitate further cost reduction and improve manufacturing agility, and serialization and drug pedigree progress remains critical to successfully reducing the explosion of counterfeit drugs. Additionally, initiatives like continuous manufacturing and quality by design (QbD) and Process Analytical Technology (PAT) aim to improve quality, reduce defects, streamline operations, and reduce corporate risk. All of these hold great long-term promise for life science companies and should help drive both top- and bottom-line expansion in the coming years."
Table of Contents
Table of Contents
IDC Health Insights Opinion
In This Study
Background
Methodology
Situation Overview
Business Needs
Management Challenges
PAT and QbD
Continuous Manufacturing/Processing
The Best Practices
Manufacturing and Supply Chain Budget Analysis
Looking Back at 2011: Manufacturing and Supply Chain IT Spend 2011 - Hardware, Software, and Services
Looking Ahead to 2012: Manufacturing and Supply Chain Budgeted IT Spend 2012 - Hardware, Software, and Services
Overall Budgeted IT Spend
Budgeted Hardware Spend
Budgeted Software Spend
Budgeted IT Services Spend
Future Outlook
Management Challenges and Planned Spending Analysis
Technology Importance
Budgeted Technology Spend for 2012
Expected Source of Purchase for 2012 Planned Technology Purchases
Essential Guidance
Actions to Consider
Learn More
Related Research
Synopsis
Table: Worldwide Pharma and Biotech Manufacturing and Supply Chain IT Spending, 2011
Table: Manufacturing and Supply Chain Overall IT Spend by Company Size, 2012
Table: Manufacturing and Supply Chain Overall IT Spend by Industry Segment, 2012
Table: Manufacturing and Supply Chain Hardware Spend by Company Size, 2012
Table: Manufacturing and Supply Chain Hardware Spend by Industry Segment, 2012
Table: Manufacturing and Supply Chain Software Spend by Company Size, 2012
Table: Manufacturing and Supply Chain Software Spend by Industry Segment, 2012
Table: Manufacturing and Supply Chain IT Services Spend by Company Size, 2012
Table: Manufacturing and Supply Chain IT Services Spend by Industry Segment, 2012
Table: Importance of IT Solutions to Manufacturing and Supply Chain Success
Table: Planned Manufacturing and Supply Chain IT Spending by IT Solution, 2012
Table: Planned Source of Manufacturing and Supply Chain IT Solutions Purchase, 2012 (% of Respondents)
Best Practices: 2012 Life Science Manufacturing and Supply Chain IT Benchmark Guide published by IDC Health Insights in June 11, 2012. This report consists of Pages: 16 and the price starts from US $ 4500.
